Does PEGASPARGASE Cause Potentiating drug interaction? 47 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Potentiating drug interaction have been filed in association with PEGASPARGASE (ONCASPAR). This represents 0.4% of all adverse event reports for PEGASPARGASE.
47
Reports of Potentiating drug interaction with PEGASPARGASE
0.4%
of all PEGASPARGASE reports
1
Deaths
32
Hospitalizations
How Dangerous Is Potentiating drug interaction From PEGASPARGASE?
Of the 47 reports, 1 (2.1%) resulted in death, 32 (68.1%) required hospitalization, and 3 (6.4%) were considered life-threatening.
Is Potentiating drug interaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGASPARGASE. However, 47 reports have been filed with the FAERS database.
What Other Side Effects Does PEGASPARGASE Cause?
Febrile neutropenia (1,589)
Pyrexia (706)
Febrile bone marrow aplasia (668)
Sepsis (548)
Vomiting (530)
Neutropenia (521)
Abdominal pain (469)
Hypertriglyceridaemia (399)
Hypotension (388)
Thrombocytopenia (382)
What Other Drugs Cause Potentiating drug interaction?
METFORMIN (150)
METHOTREXATE (119)
QUETIAPINE (98)
ASPIRIN (87)
RIVAROXABAN (71)
PREGABALIN (67)
TACROLIMUS (56)
AMIODARONE (53)
CLARITHROMYCIN (52)
GABAPENTIN (52)
Which PEGASPARGASE Alternatives Have Lower Potentiating drug interaction Risk?
PEGASPARGASE vs PEGASYS
PEGASPARGASE vs PEGCETACOPLAN
PEGASPARGASE vs PEGFILGRASTIM
PEGASPARGASE vs PEGFILGRASTIM-APGF
PEGASPARGASE vs PEGFILGRASTIM-BMEZ